Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Laparoscopy training in gynecologic oncology fellowship programs.
Frumovitz M, Soliman PT, Greer M, Schmeler KM, Moroney J, Bodurka DC, Ramirez PT. Frumovitz M, et al. Among authors: moroney j. Gynecol Oncol. 2008 Nov;111(2):197-201. doi: 10.1016/j.ygyno.2008.08.008. Epub 2008 Sep 20. Gynecol Oncol. 2008. PMID: 18804849
Aflibercept in epithelial ovarian carcinoma.
Moroney JW, Sood AK, Coleman RL. Moroney JW, et al. Future Oncol. 2009 Jun;5(5):591-600. doi: 10.2217/fon.09.35. Future Oncol. 2009. PMID: 19519199 Free PMC article. Review.
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.
Janku F, Tsimberidou AM, Garrido-Laguna I, Wang X, Luthra R, Hong DS, Naing A, Falchook GS, Moroney JW, Piha-Paul SA, Wheler JJ, Moulder SL, Fu S, Kurzrock R. Janku F, et al. Among authors: moroney jw. Mol Cancer Ther. 2011 Mar;10(3):558-65. doi: 10.1158/1535-7163.MCT-10-0994. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216929 Free PMC article.
Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer.
Moulder S, Moroney J, Helgason T, Wheler J, Booser D, Albarracin C, Morrow PK, Koenig K, Kurzrock R. Moulder S, et al. Among authors: moroney j. J Clin Oncol. 2011 Jul 1;29(19):e572-5. doi: 10.1200/JCO.2010.34.0604. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21482991 Clinical Trial. No abstract available.
Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity.
Moroney J, Fu S, Moulder S, Falchook G, Helgason T, Levenback C, Hong D, Naing A, Wheler J, Kurzrock R. Moroney J, et al. Clin Cancer Res. 2012 Oct 15;18(20):5796-805. doi: 10.1158/1078-0432.CCR-12-1158. Epub 2012 Aug 27. Clin Cancer Res. 2012. PMID: 22927482 Clinical Trial.
206 results